Compounds > paroxetine
Page last updated: 2024-08-23

paroxetine and Diabetes Mellitus

paroxetine has been researched along with Diabetes Mellitus in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, MY; Jia, LL; Li, F; Liu, C; Liu, L; Liu, XD; Xu, D; Yang, Y; Zhang, M; Zhong, ZY1
Andersohn, F; Garbe, E; Schade, R; Suissa, S1
Altman, RB; Castro, V; Denny, JC; Fernald, GH; Kohane, I; Krishnan, G; Murphy, SN; Roden, DM; Tatonetti, NP; Tsao, PS; Tsau, PS; Yue, P1
Boura-Halfon, S; Gurevitch, D; Isaac, R; Levkovitz, Y; Shainskaya, A; Zick, Y1
Ben-Shushan, G; Gil-Ad, I; Hershkovitz, A; Isaac, R; Levkovitz, Y; Ronen, D; Shvartsman, D; Weizman, A; Zick, Y1

Other Studies

5 other study(ies) available for paroxetine and Diabetes Mellitus

ArticleYear
Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure.
    Acta pharmacologica Sinica, 2014, Volume: 35, Issue:6

    Topics: Animals; Anticholesteremic Agents; Antidepressive Agents, Second-Generation; Blood Glucose; Cell Line; Depression; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Drug Interactions; Hypercholesterolemia; Insulin; Male; Paroxetine; Pravastatin; Rats; Rats, Sprague-Dawley; Serotonin

2014
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.
    The American journal of psychiatry, 2009, Volume: 166, Issue:5

    Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder; Diabetes Mellitus; Female; Fluvoxamine; Humans; Incidence; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; United Kingdom; Venlafaxine Hydrochloride

2009
Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.
    Clinical pharmacology and therapeutics, 2011, Volume: 90, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Algorithms; Blood Glucose; Cohort Studies; Data Mining; Diabetes Mellitus; Drug Interactions; Electronic Health Records; Ethnicity; Female; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Paroxetine; Pravastatin; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Socioeconomic Factors; United States; United States Food and Drug Administration

2011
Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.
    The Journal of biological chemistry, 2013, Feb-22, Volume: 288, Issue:8

    Topics: Animals; Apoptosis; Cell Death; Cell Line; Diabetes Mellitus; Fluoxetine; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction; Unfolded Protein Response

2013
Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases.
    Molecular and cellular neurosciences, 2007, Volume: 36, Issue:3

    Topics: Animals; Cell Line, Tumor; Diabetes Mellitus; Enzyme Activation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Metabolic Syndrome; Paroxetine; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Selective Serotonin Reuptake Inhibitors; Serine; Sertraline; Signal Transduction

2007